Drawing for FILLDERM

USPTO serial 79341039

FILLDERM

Reviewed by CopyMark Law Group

Reg. 7203922Status 700Registered
Filing date
Status date
Registration date
Oct 31, 2023
Examiner
LOZEAU, BRANDON THOMAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FILLDERM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William S. Fultz

William S. Fultz Womble Bond Dickinson (US) LLP555 Fayetteville Street, Suite 1100Raleigh, NC 27601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in dermatology; injectable preparations for medical and pharmaceutical purposes, namely, injectable dermal fillers; pharmaceutical preparations made from hyaluronic acid for use in dermatology; pharmaceutical preparations made from lidocaine for use in dermatology; injectable preparations made from lidocaine for use as local anesthetics; injectable preparations made from hyaluronic acid for use in dermatology; filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; pre-filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 9, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 26, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2024FIMPFINAL DISPOSITION PROCESSED—
Jan 31, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 25, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 25, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 20, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 30, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 30, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 30, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 28, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 28, 2023RFRRREFUSAL PROCESSED BY MPU—
Feb 1, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 31, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 30, 2023DOCKASSIGNED TO EXAMINER—
May 27, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 23, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance